BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Youhanna S, Wright SC, Lauschke VM. Organotypic human ex vivo models for coronavirus disease 2019 research and drug development. Curr Opin Pharmacol 2021;59:11-8. [PMID: 34029832 DOI: 10.1016/j.coph.2021.04.006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Basu A, Pamreddy A, Singh P, Sharma K. An Adverse Outcomes Approach to Study the Effects of SARS-CoV-2 in 3D Organoid Models. J Mol Biol 2021;:167213. [PMID: 34437890 DOI: 10.1016/j.jmb.2021.167213] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Larijani B, Foroughi-Heravani N, Abedi M, Tayanloo-Beik A, Rezaei-Tavirani M, Adibi H, Arjmand B. Recent Advances of COVID-19 Modeling Based on Regenerative Medicine. Front Cell Dev Biol 2021;9:683619. [PMID: 34760882 DOI: 10.3389/fcell.2021.683619] [Reference Citation Analysis]
3 Youhanna S, Kemas AM, Preiss L, Zhou Y, Shen JX, Cakal SD, Paqualini FS, Goparaju SK, Shafagh RZ, Lind JU, Sellgren CM, Lauschke VM. Organotypic and Microphysiological Human Tissue Models for Drug Discovery and Development-Current State-of-the-Art and Future Perspectives. Pharmacol Rev 2022;74:141-206. [PMID: 35017176 DOI: 10.1124/pharmrev.120.000238] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]